Streetbeat News

Analyst Ratings

LVLU

Goldman Sachs analyst Brooke Roach has maintained a Neutral rating on Lulus Fashion Lounge (NASDAQ:LVLU) and lowered the price target from $2.25 to $2.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:18 pm

LYFT

Wedbush analyst Daniel Ives maintains a Neutral rating on Lyft (NASDAQ:LYFT) and raises the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:17 pm

DUOL

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Duolingo (NASDAQ:DUOL) and raised the price target from $140 to $160.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:17 pm

ELF

Spruce Point Capital Management has released a report expressing strong sell research opinion on e.l.f. Beauty, Inc. (NYSE:ELF). The report questions e.l.f. Beauty's partnership with Movers+Shakers, an advertising agency co-founded by former members of the NXIVM cult. Spruce Point suggests that e.l.f. Beauty's marketing messages are similar to those used within the NXIVM cult and questions whether e.l.f. Beauty's core values align with retail partners such as Walmart, Target, and Ulta Beauty. Spruce Point sees a 45% to 65% long-term downside risk to e.l.f. Beauty's share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:14 pm

DISH

Goldman Sachs analyst Brett Feldman has maintained a Neutral rating on DISH Network (NASDAQ:DISH) and lowered the price target from $6 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:14 pm

CRSR

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Corsair Gaming (NASDAQ:CRSR) and lowered the price target from $20 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:12 pm

YOU

Goldman Sachs analyst Benjamin Miller maintains a Buy rating on Clear Secure (NYSE:YOU) and raises the price target from $24 to $27.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:11 pm

BMBL

Goldman Sachs analyst Alexandra Steiger maintains a Buy rating on Bumble (NASDAQ:BMBL) but lowers the price target from $23 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:09 pm

PHVS

Pharvaris (NASDAQ:PHVS) announced the presentation of two ePosters at the ACAAI 2023 Annual Scientific Meeting. The posters will present clinical data on Deucrictibant, a drug being developed to treat hereditary angioedema (HAE), and real-world HAE treatment satisfaction data. The phase 2 RAPIDe-1 trial showed that PHVS416 (immediate-release deucrictibant capsules) reduced time to symptom relief and use of rescue medication. The company aims to develop this formulation to provide rapid and reliable symptom relief in an easy-to-administer, small oral dosage form.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:08 pm

ARRY

Goldman Sachs analyst Brian Lee maintains a Buy rating on Array Technologies (NASDAQ:ARRY) but has lowered the price target from $36 to $31.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 4:07 pm